Clinical Chemistry Phenobarbital, list number 1E08

FDA Device Recall #Z-1118-2013 — Class II — November 16, 2012

Recall Summary

Recall Number Z-1118-2013
Classification Class II — Moderate risk
Date Initiated November 16, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Laboratories, Inc
Location Irving, TX
Product Type Devices
Quantity 1289

Product Description

Clinical Chemistry Phenobarbital, list number 1E08

Reason for Recall

Abbott Diagnostics is recalling Clinical Chemistry Phenobarbital reagent lots 62299UN12 and 85773UN12 due to imprecision issues which increase with the age of the reagent lot. The imprecision of the Phenobarbital assay is d 7% Total CV%; however, internal testing confirmed CVs up to approximately 12% for in-date reagent lots over five months old. Although lot 52803UN12 is now expired, it exhibit

Distribution Pattern

Worldwide Distribution - USA (nationwide) and Internationally to Internationally distributed to Argentina, Australia, Austria, Bahamas, Brunei, Canada, Chile, Curacao, Denmark, France, Germany, Greece, Ireland, Italy, Lebanon, Mexico, Netherlands, Norway, Oman, Paraguay, Portugal, Puerto Rico, Russia, Saudi Arabia, Serbia, South Korea, Spain, Switzerland, Turkey, and United Kingdom.

Lot / Code Information

Lot Numbers 52803UN12, 62299UN12, and 85773UN12

Other Recalls from Abbott Laboratories, Inc

Recall # Classification Product Date
Z-0749-2022 Class II Alinity s System software version2.8.0, REF LN ... Feb 3, 2022
Z-2276-2021 Class II Alinity s System REF 06P16-01. An automated i... Jul 12, 2021
Z-1671-2020 Class II ARCHITECT C System Mixer - Product Usage: The A... May 1, 2019
Z-0971-2019 Class II ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-... Jan 2, 2019
Z-2755-2019 Class II APS Accelerator modular systems, 208-230 V-, 50... Sep 7, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.